- Dr. Lewis-Hall has spent more than 40 years on the frontlines of healthcare as a clinician, researcher, and leader in the biopharmaceuticals and life sciences industries.
- She was most recently a top executive at Pfizer, Inc.
- The Council provides strategic advice, assists with raising funds, and builds awareness.
The Foundation is pleased to welcome Freda Lewis-Hall, MD, DFAPA, MFPM, to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness.
Dr. Lewis-Hall is a pioneer in medicine, having spent more than 40 years on the frontlines of healthcare as a clinician, researcher, and leader in the biopharmaceutical and life sciences industries.
Most recently, at Pfizer, Inc, Dr. Lewis-Hall served more than ten years on the executive leadership team as executive vice president, chief medical officer, and later chief patient officer. Her tenure at Pfizer was devoted to ensuring the safe, effective, and appropriate use of medicines and vaccines produced by the pharmaceutical giant, from the first clinical trial to its last use.
Prior to joining Pfizer, Dr. Lewis-Hall held senior leadership roles at Vertex Pharmaceuticals, Bristol-Myers Squibb, Pharmacia Corporation, and Eli Lilly and Company.
“Freda brings a multifaceted perspective on healthcare that is perfectly suited to assist the Foundation’s mission of guiding focused ultrasound toward a mainstream therapy,” says Foundation Chairman Neal F. Kassell, MD. “She is a strong advocate for patients, and her experience in the biopharmaceutical industry and government advocacy for healthcare disparities is an invaluable asset to our Council. We are honored to have her involved with the Foundation.”
Before entering the biopharmaceutical industry, Dr. Lewis-Hall held positions in the National Institute of Mental Health and the Department of Psychiatry at Howard University College of Medicine, where she earned her medical degree. She also recently completed a decade of service on the inaugural Board of Governors for the Patient-Centered Outcomes Research Institute (PCORI).
Dr. Lewis-Hall serves on the Boards of the Foundation of the National Institutes of Health, The Milken Institute’s FasterCures Center, the Prostate Cancer Foundation, the Davos Alzheimer’s Collaborative, and the Dalio Center for Health Justice at NewYork-Presbyterian. She also serves on the corporate boards of Milliken and Company, a global diversified industrial manufacturer; 1Life Healthcare, Inc., a health services company; Exact Sciences, Inc., a molecular diagnostics company; and SpringWorks Therapeutics, a biopharmaceutical company. She is also a member of the Board of Fellows of The Harvard Medical School, and the Board of Advisors of the Dell Medical School.
“I am passionate about advancing the development, delivery, and deployment of transformational technologies with the potential to save or improve lives,” said Dr. Lewis-Hall. “I believe focused ultrasound to be such a technology and am honored to join the Council of the Focused Ultrasound Foundation whose mission is to advance and support this work.”